SEC Form 4 · accession 0001354488-17-000033
TG THERAPEUTICS, INC. · TGTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael S Weiss
Officer — CEO and President · Director · 10% Owner
Period of report
Dec 30, 2016
Accepted (ET)
Jan 4, 2017 · 4:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001001316
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock (Restricted)F1,F2 | Jan 1, 2017 | D | 3,381,866 | $0.00 | D | 6,073,796 | D | |
| Common Stock (Restricted)F3,F4 | Jan 1, 2017 | A | 2,960,000 | $0.00 | A | 9,033,796 | I | See Note 4 |
| Common Stock (Restricted)F5 | Jan 1, 2017 | A | 418,371 | $0.00 | A | 9,452,167 | D | |
| Common Stock (Restricted)F6,F4 | Dec 30, 2016 | A | 693,750 | $0.00 | A | 10,145,917 | I | See Note 4 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Mr. Weiss forfeited the shares pursuant to an amendment to his employment agreement effective as of January 1, 2017.
- F2Included in Mr. Weiss' beneficial ownership are 4,499,560 shares of Common Stock and 410,450 warrants to purchase Common Stock at $2.48, exercisable through February 24, 2017 issued to Opus Point Partners, LLC, of which Mr. Weiss is a co-founder, managing partner, and principal and beneficially owns a 50% interest.
- F3Represents shares of restricted stock which vest based on certain market capitalization milestones.
- F4The shares are held by Caribe BioAdvisors, LLC, of which Mr. Weiss is the sole member.
- F5375,000 shares vest on December 1, 2018 and 43,371 shares vest on December 1, 2019.
- F6Reflects an annual grant of restricted stock pursuant to Mr. Weiss? employment agreement to be held by Caribe BioAdvisors, LLC. The restricted shares will vest according to the following schedule: 25% on January 1, 2018; 25% on January 1, 2019; and 50% on the date that the Company's Market Capitalization is $100 million greater than the Market Capitalization on December 31, 2016.